GM27289
LCL from B-Lymphocyte
Description:
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25; EIEE25
SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT CITRATE TRANSPORTER), MEMBER 5; SLC13A5
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases PIGI Consented Sample |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
Italian, German, Welsh
|
Country of Origin
|
USA
|
Family Member
|
2
|
Family History
|
Y
|
Relation to Proband
|
brother
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
SLC13A5 |
Chromosomal Location |
17p13.1 |
Allelic Variant 1 |
608305..0001; EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25 |
Identified Mutation |
c.655G>A (p.G219R) |
|
Gene |
SLC13A5 |
Chromosomal Location |
17p13.1 |
Allelic Variant 1 |
p.LEU492PRO (p.L492P); EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25 |
Identified Mutation |
c.1475T>C (p.L492P) |
Demographic Data |
Relation to Proband |
brother |
Age at Sampling |
4 YR |
Sex |
Male |
Hispanic or Latino/Not Hispanic or Latino |
Not Hispanic/Latino |
Racial Category |
White |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
WHOLE EXOME SEQUENCING REVEALED TWO VARIANTS IN THE SLC13A5 GENE IN TRANS CONFIGURATION (COMPOUND HETEROZYGOUS): SLC13A5 C.655G>A (P.G219R) EXON 5; SLC13A5 C.1475T>C (P.L492P) EXON 11 |
Zygosity: |
Compound Heterozygous Notes: VARIANT C.655G>A (P.G219R) KNOWN TO BE PATHOGENIC; VARIANT C.1475T>C (P.L492P) IS LIKELY PATHOGENIC |
Other variants: |
WDR81, C.3532G>A (P.A1178T), EXON 1, RS151330612, HETEROZYGOUS; MOCS1, C.*679T>C, 3'UTR, NOVEL VARIANT, HETEROZYGOUS |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
BIRTH |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
|
Neurological Symptoms |
|
Ataxia Hypotonia Seizures
|
Optical and Audiological Symptoms |
|
|
Musculoskeletal Symptoms |
|
Scoliosis
|
Developmental Milestones |
|
|
Gastrointestinal Symptoms |
|
|
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
|
Intellectual Disability: |
Severe |
Additional Information |
Testing Performed |
Treatments and Assistive Devices |
|
|
Medications |
Family History |
|
PATIENT'S SIBLING (GM27288) ALSO COMPOUND HETEROZYGOUS FOR THESE TWO VARIANTS; MOTHER (GM27290) IS APPARENTLY HEALTHY AND HETEROZYGOUS FOR THE C.1475T>C (P.L492P) VARIANT; FATHER (GM27299) IS APPARENTLY HEALTHY AND HETEROZYGOUS FOR THE C.655G>A (P.G219R) PATHOGENIC VARIANT. |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|